Invention Grant
- Patent Title: Antibody binding TIM-3 and use thereof
-
Application No.: US17046388Application Date: 2019-04-11
-
Publication No.: US11807683B2Publication Date: 2023-11-07
- Inventor: Xiaoqiang Kang , Shoupeng Lai , Xiao Huang
- Applicant: Nanjing Leads Biolabs Co., Ltd.
- Applicant Address: CN Jiangsu
- Assignee: Nanjing Leads Biolabs Co., Ltd.
- Current Assignee: Nanjing Leads Biolabs Co., Ltd.
- Current Assignee Address: CN Nanjing
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/CN2019/082318 2019.04.11
- International Announcement: WO2019/196911A 2019.10.17
- Date entered country: 2020-10-09
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K38/20 ; A61K39/00
Abstract:
The present invention provides an isolated monoclonal antibody that specifically binds human TIM-3. The present invention further provides a pharmaceutical composition comprising the antibody, as well as uses thereof.
Public/Granted literature
- US20210221885A1 ANTIBODY BINDING TIM-3 AND USE THEREOF Public/Granted day:2021-07-22
Information query
